HIL Applied Medical
HIL Lands European Union’s Most Prestigious Financing Today HIL won what is by far the most competitive and prestigious financing program the European Union has to offer: Horizon 2020 EIC Accelerator, blended financing. Out of over 4,200 applicants, The European Commission …
Continue reading »Excited to take part in the first business delegation from Israel to Dubai HIL’s CEO Sagi Brink-Danan is one of 200+ Israeli representatives who took a direct flight to Dubai this week to take part in the first business summit …
Continue reading »R&D Project / Team Leader, Charged Particles Beamline Description of the Position: The particle beam team / project manager is responsible to lead the development of a beam transport system that will deliver the charged particles from the accelerator to …
Continue reading »HIL featured in Pitango map of the Israeli healthcare startup industry on Calcalist Magazine Since the Covid-19 outbreak in January, hardly a week goes by without an Israeli healthcare breakthrough making headlines. The healthcare ecosystem has been on the rise …
Continue reading »A Consortium led by HIL wins major R&D grant by European Union The European Commission managing Horizon 2020 – the EU Framework Program for Research and Innovation – today announced its decision to fully fund a proposal by HIL and its …
Continue reading »Dr. Ehud (Udi) Netzer is named Chairman at HIL. Dr. Netzer joined HIL’s Board of Directors last year and was today appointed by HIL’s Board of Directors as Chairman. In recent months he was intimately involved with Israel’s response to the COVID-19 epidemic, …
Continue reading »We’re on the Map! HIL featured in The Marker Magazine STARTUP NATION HIGH-TECH MAP: The Marker magazine tells the story of HIL Applied Medical and its unique Proton Therapy solution within the startup nation high-tech map project. HIL was featured as one of the Israeli startup …
Continue reading »HIL at JP Morgan Healthcare Conference – the CICC Israel Lounge HIL will partake in the CICC’s Israel Lounge, on January 13-14th, during the JP Morgan Healthcare conference. Come and meet 1×1 with our CEO Sagi Brink-Danan, to get the latest …
Continue reading »HIL awarded €2.5M in grant funding by the EU The European Commission managing Horizon 2020 – the EU Framework Programme for Research and Innovation – today approved HIL’s Phase-II proposal, at a total budget of €3.3M. The positive funding decision, …
Continue reading »Dr. Raphael Pfeffer, Assuta Chief Of Oncology and HIL Advisory Board Member, in an interview on the future of radiation therapy For its Medicine 2020 special issue The Marker Magazine featured an interview with Dr. Raphael (Raphi) Pfeffer, HIL’s advisory …
Continue reading »